Keito Okazaki

575 total citations
11 papers, 347 citations indexed

About

Keito Okazaki is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Keito Okazaki has authored 11 papers receiving a total of 347 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Immunology and 2 papers in Cancer Research. Recurrent topics in Keito Okazaki's work include Genomics, phytochemicals, and oxidative stress (5 papers), Glycosylation and Glycoproteins Research (2 papers) and Glutathione Transferases and Polymorphisms (2 papers). Keito Okazaki is often cited by papers focused on Genomics, phytochemicals, and oxidative stress (5 papers), Glycosylation and Glycoproteins Research (2 papers) and Glutathione Transferases and Polymorphisms (2 papers). Keito Okazaki collaborates with scholars based in Japan, United States and Canada. Keito Okazaki's co-authors include Hozumi Motohashi, Hiroki Sekine, Hiroki Shima, Shohei Murakami, Kazuhiko Igarashi, Nao Ota, Md. Morshedul Alam, Thales Papagiannakopoulos, Takaaki Akaike and Masayuki Yamamoto and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Molecular and Cellular Biology.

In The Last Decade

Keito Okazaki

11 papers receiving 345 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keito Okazaki Japan 6 264 42 40 28 27 11 347
Chang Yan Chen United States 11 313 1.2× 72 1.7× 22 0.6× 25 0.9× 27 1.0× 12 461
Md. Morshedul Alam Bangladesh 8 191 0.7× 21 0.5× 28 0.7× 20 0.7× 35 1.3× 24 348
Bhupendra Singh United States 10 326 1.2× 63 1.5× 21 0.5× 25 0.9× 21 0.8× 13 445
Im Sun Woo South Korea 12 300 1.1× 61 1.5× 38 0.9× 50 1.8× 20 0.7× 15 396
Yangxia Li China 4 310 1.2× 35 0.8× 28 0.7× 12 0.4× 47 1.7× 4 383
Xue Gao China 12 225 0.9× 66 1.6× 29 0.7× 12 0.4× 21 0.8× 31 395
Phanithi Prakash Babu India 12 148 0.6× 50 1.2× 34 0.8× 22 0.8× 11 0.4× 19 344
Ibrul Chowdhury United States 8 289 1.1× 22 0.5× 36 0.9× 19 0.7× 14 0.5× 11 372
Brig Mecham United States 7 335 1.3× 35 0.8× 24 0.6× 25 0.9× 30 1.1× 8 462

Countries citing papers authored by Keito Okazaki

Since Specialization
Citations

This map shows the geographic impact of Keito Okazaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keito Okazaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keito Okazaki more than expected).

Fields of papers citing papers by Keito Okazaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keito Okazaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keito Okazaki. The network helps show where Keito Okazaki may publish in the future.

Co-authorship network of co-authors of Keito Okazaki

This figure shows the co-authorship network connecting the top 25 collaborators of Keito Okazaki. A scholar is included among the top collaborators of Keito Okazaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keito Okazaki. Keito Okazaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Hayashi, Makiko, et al.. (2024). The Complex Roles of Redox and Antioxidant Biology in Cancer. Cold Spring Harbor Perspectives in Medicine. 14(11). a041546–a041546. 3 indexed citations
2.
Murakami, Shohei, et al.. (2023). NRF2 signalling in cytoprotection and metabolism. British Journal of Pharmacology. 183(1). 101–114. 58 indexed citations
3.
Hayasaka, Kazuki, Shinya Ohkouchi, Ryoko Saito, et al.. (2023). Aging exacerbates murine lung ischemia-reperfusion injury by excessive inflammation and impaired tissue repair response. American Journal of Transplantation. 24(2). 293–303. 1 indexed citations
4.
Okazaki, Keito, et al.. (2022). CEBPB is required for NRF2-mediated drug resistance in NRF2-activated non-small cell lung cancer cells. The Journal of Biochemistry. 171(5). 567–578. 20 indexed citations
5.
Okazaki, Keito, Thales Papagiannakopoulos, & Hozumi Motohashi. (2020). Metabolic features of cancer cells in NRF2 addiction status. Biophysical Reviews. 12(2). 435–441. 41 indexed citations
6.
Sekine, Hiroki, Keito Okazaki, Koichiro Kato, et al.. (2018). O-GlcNAcylation Signal Mediates Proteasome Inhibitor Resistance in Cancer Cells by Stabilizing NRF1. Molecular and Cellular Biology. 38(17). 51 indexed citations
7.
Alam, Md. Morshedul, Keito Okazaki, Nao Ota, et al.. (2017). Glucocorticoid receptor signaling represses the antioxidant response by inhibiting histone acetylation mediated by the transcriptional activator NRF2. Journal of Biological Chemistry. 292(18). 7519–7530. 96 indexed citations
8.
Sekine, Hiroki, Keito Okazaki, Nao Ota, et al.. (2015). The Mediator Subunit MED16 Transduces NRF2-Activating Signals into Antioxidant Gene Expression. Molecular and Cellular Biology. 36(3). 407–420. 72 indexed citations
9.
Toi, Yukihiro, Shunichi Sugawara, Takao Kobayashi, et al.. (2012). Prospective study of chemotherapy-induced  clostridium difficile infection in lung cancer patients.. Journal of Clinical Oncology. 30(15_suppl). e19521–e19521. 1 indexed citations
10.
Asada, Masanori, et al.. (2011). [Severe community-acquired pneumonia due to Acinetobacter baumannii].. PubMed. 49(10). 760–4. 3 indexed citations
11.
Morita, Miyo Terao, Keito Okazaki, & Yoko Yamamoto. (1987). [A new gastrointestinal mucinous antigen prepared by using a monoclonal antibody, and it's characterization].. PubMed. 84(8). 1616–22. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026